Raising the Limits

See allHide authors and affiliations

Science  28 Jun 2002:
Vol. 296, Issue 5577, pp. 2322
DOI: 10.1126/science.296.5577.2322

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The impressive flow of new anti-HIV drugs--10 have been approved in the past 6 years--is giving researchers hope that they can alleviate some of the problems with current therapies (see main text). But the array of choices can be bewildering for physicians. And it is only going to get more complicated.